Skip to main content
Fig. 3 | Insights into Imaging

Fig. 3

From: Medical imaging in personalised medicine: a white paper of the research committee of the European Society of Radiology (ESR)

Fig. 3

18FDG imaging to monitor cancer treatment. Computed tomography (CT, left), 18FDG positron emission tomography (PET, right) and PET/CT fusion (middle) images in a patient with Hodgkin’s lymphoma, evaluated after eight courses of chemotherapy. Intense hypermetabolism on FDG-PET corresponds with localisation on CT in a small right supraclavicular lymph node, clearly indicating recurrent lymphoma. (Figure courtesy of Dr. Roelf Valkema, Department of Nuclear Medicine, Erasmus MC)

Back to article page